Airspan Networks Holdings Inc. Reports 2022 Results
Airspan Networks Holdings Inc. (NYSE American: MIMO) reported its financial results for the full year and fourth quarter ending December 31, 2022.
Fourth quarter revenue stood at $41.7 million, marking a 1% increase sequentially but a 17% decrease year-over-year. The gross margin improved to 46.1% from 39.8% in the previous quarter. Net loss narrowed to $11.3 million, down from $23.3 million in Q3 2022.
For the full year, revenues totaled $167.3 million, a 6% decline from 2021, with a net loss of $85.4 million, compared to $70.5 million in the previous year.
- Fourth quarter gross margin increased to 46.1%, up from 39.8% in Q3 2022.
- Operating expenses decreased to $27.0 million from $33.1 million in Q3 2022, enhancing cost management.
- Fourth quarter revenue decreased 17% year-over-year despite a 1% sequential increase.
- Full year revenue declined 6%, indicating potential ongoing challenges in market demand.
- Net loss for the full year increased to $85.4 million from $70.5 million in 2021.
Key Fourth Quarter Financial Highlights
-
Revenue of
, increased$41.7 million 1% sequentially from third quarter 2022, and decreased17% year-over-year -
Gross margin of
46.1% was up from39.8% in the third quarter 2022 and up from41.1% in fourth quarter 2021 -
Total operating expenses of
compared to$27.0 million in third quarter 2022, and$33.1 million for fourth quarter 2021$37.5 million -
Net loss of
, compared to a net loss of$11.3 million in third quarter 2022, and a net loss of$23.3 million for fourth quarter 2021$19.6 million -
Adjusted EBITDA (non-GAAP measure) was a loss of
compared to a loss of$5.0 million in third quarter 2022 and a loss of$10.0 million in fourth quarter 2021$8.0 million -
Loss per share was
15 cents , compared to loss per share of32 cents in third quarter 2022 and a loss per share of27 cents in fourth quarter 2021
Key 2022 Financial Highlights
-
Revenue of
decreased$167.3 million 6% year-over-year -
Gross margin of
39.7% was down from44.0% in 2021 -
Total operating expenses of
compared to$134.4 million in 2021$139.3 million -
Net loss of
, compared to a net loss of$85.4 million for 2021$70.5 million -
Adjusted EBITDA (non-GAAP measure) was a loss of
compared to a loss of$45.2 million in 2021$29.1 million -
Loss per share was
compared to a loss per share of$1.17 in 2021$1.09
Improved Operating Margins and Expense Control Drive Continued Adjusted EBITDA Improvement
-
Adjusted EBITDA improved from a loss of
in Q122 to a loss of$18.0 million in Q422 as a result of higher gross margins due to product mix and lower operating expenses recorded as a result of the reductions in headcount.$5.0 million
Summary Results of Operations Adjusted for Share-based Compensation, Depreciation, Amortization and Restructuring costs | ||||||||||||
($ in thousands) | Q122 | Q222 | Q322 | Q422 | 2022 |
|||||||
Revenue | $ | 37,564 |
$ | 46,945 |
$ | 41,094 |
$ | 41,656 |
$ | 167,259 |
||
Gross Profit | 12,069 |
18,828 |
16,336 |
19,207 |
66,440 |
|||||||
Gross Margin |
|
|
|
|
|
|||||||
Adjusted Operating expenses (Non-GAAP) | (1) |
29,608 |
28,977 |
25,114 |
23,719 |
107,418 |
||||||
Adjusted Loss from Operations (Non-GAAP) | (2) |
(17,539) |
(10,149) |
(8,778) |
(4,512) |
(40,978) |
||||||
Other expense, net | (506) |
(2,126) |
(1,177) |
(452) |
(4,261) |
|||||||
Adjusted EBITDA (Non-GAAP) | (3) |
$ | (18,045) |
$ | (12,275) |
$ | (9,955) |
$ | (4,964) |
$ | (45,239) |
|
(1) |
The following table presents the reconciliation of Total Operating Expenses the most directly comparable GAAP measure, to Adjusted Operating expenses (Non-GAAP) | |||||||||||
($ in thousands) | Q122 | Q222 | Q322 | Q422 | 2022 |
|||||||
Total Operating Expenses | $ | 37,293 |
$ | 37,103 |
$ | 33,094 |
$ | 26,959 |
$ | 134,449 |
||
Adjusted for: | ||||||||||||
Share-based compensation expense | (6,564) |
(6,972) |
(5,863) |
(1,732) |
(21,131) |
|||||||
Depreciation and amortization | (1,121) |
(1,154) |
(1,173) |
(1,174) |
(4,622) |
|||||||
Restructuring | - |
- |
(944) |
(334) |
(1,278) |
|||||||
Adjusted Operating expenses (Non-GAAP) | $ | 29,608 |
$ | 28,977 |
$ | 25,114 |
$ | 23,719 |
$ | 107,418 |
||
(2) |
The following table presents the reconciliation of Loss from Operations the most directly comparable GAAP measure, to Adjusted Loss from Operations (Non-GAAP) | |||||||||||
($ in thousands) | Q122 | Q222 | Q322 | Q422 | 2022 |
|||||||
Loss from Operations | $ | (25,224) |
$ | (18,275) |
$ | (16,758) |
$ | (7,752) |
$ | (68,009) |
||
Adjusted for: | ||||||||||||
Share-based compensation expense | 6,564 |
6,972 |
5,863 |
1,732 |
21,131 |
|||||||
Depreciation and amortization | 1,121 |
1,154 |
1,173 |
1,174 |
4,622 |
|||||||
Restructuring | - |
- |
944 |
334 |
1,278 |
|||||||
Adjusted Loss from Operations (Non-GAAP) | $ | (17,539) |
$ | (10,149) |
$ | (8,778) |
$ | (4,512) |
$ | (40,978) |
||
(3) |
The following table presents the reconciliation of Net loss the most directly comparable GAAP measure, to Adjusted EBITDA (Non-GAAP) | |||||||||||
($ in thousands) | Q122 | Q222 | Q322 | Q422 | 2022 |
|||||||
Net loss | $ | (29,738) |
$ | (21,017) |
$ | (23,314) |
$ | (11,313) |
$ | (85,382) |
||
Adjusted for: | ||||||||||||
Interest expense | 4,568 |
4,207 |
4,296 |
7,323 |
20,394 |
|||||||
Income tax benefit | (103) |
(112) |
163 |
(145) |
(197) |
|||||||
Depreciation and amortization | 1,121 |
1,154 |
1,173 |
1,174 |
4,622 |
|||||||
EBITDA | $ | (24,152) |
$ | (15,768) |
$ | (17,682) |
$ | (2,961) |
$ | (60,563) |
||
Share-based compensation expense | 6,564 |
6,972 |
5,863 |
1,731 |
21,130 |
|||||||
Change in fair value of warrant liability and derivatives | (457) |
(3,479) |
920 |
(4,069) |
(7,085) |
|||||||
Restructuring costs | - |
- |
944 |
335 |
1,279 |
|||||||
Adjusted EBITDA (Non-GAAP) | $ | (18,045) |
$ | (12,275) |
$ | (9,955) |
$ | (4,964) |
$ | (45,239) |
About
Source:
Non-GAAP Measures
This news release references non-GAAP measures. Non-GAAP measures do not have a standardized meaning and are, therefore, unlikely to be comparable to similar measures presented by other companies. The presentation of this financial information, which is not prepared under any comprehensive set of accounting rules or principles, is not intended to be considered in isolation of, or as a substitute for, the financial information prepared and presented in accordance with US generally accepted accounting principles. Non-GAAP financial measures referred to in this report are labeled as “non-GAAP measure.”
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (in thousands, except for share data) |
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
|
2022 |
|
|
2021 |
|
||
ASSETS |
|
|
|
|
|
|
|
|
Current assets: |
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
7,253 |
|
|
$ |
62,937 |
|
Restricted cash |
|
|
34 |
|
|
|
185 |
|
Accounts receivable, net of allowance of |
|
|
46,565 |
|
|
|
57,980 |
|
Inventory |
|
|
18,556 |
|
|
|
17,217 |
|
Prepaid expenses and other current assets |
|
|
17,289 |
|
|
|
18,833 |
|
Total current assets |
|
|
89,697 |
|
|
|
157,152 |
|
Property, plant and equipment, net |
|
|
7,351 |
|
|
|
7,741 |
|
|
|
|
13,641 |
|
|
|
13,641 |
|
Intangible assets, net |
|
|
5,302 |
|
|
|
6,438 |
|
Right-of-use assets, net |
|
|
5,697 |
|
|
|
6,585 |
|
Other non-current assets |
|
|
3,407 |
|
|
|
3,942 |
|
Total assets |
|
$ |
125,095 |
|
|
$ |
195,499 |
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS’ DEFICIT |
|
|
|
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
|
|
|
Accounts payable |
|
$ |
26,173 |
|
|
$ |
29,709 |
|
Accrued expenses and other current liabilities |
|
|
32,243 |
|
|
|
26,967 |
|
Deferred revenue |
|
|
2,892 |
|
|
|
2,902 |
|
Senior term loan, current portion |
|
|
40,529 |
|
|
|
3,187 |
|
Subordinated debt |
|
|
11,119 |
|
|
|
10,577 |
|
Subordinated term loan - related party |
|
|
41,528 |
|
|
|
- |
|
Convertible debt |
|
|
43,928 |
|
|
|
- |
|
Current portion of long-term debt |
|
|
259 |
|
|
|
275 |
|
Total current liabilities |
|
|
198,671 |
|
|
|
73,617 |
|
Subordinated term loan - related party |
|
|
- |
|
|
|
37,991 |
|
Senior term loan |
|
|
- |
|
|
|
37,876 |
|
Convertible debt |
|
|
- |
|
|
|
41,343 |
|
Other long-term liabilities |
|
|
7,223 |
|
|
|
20,924 |
|
Total liabilities |
|
|
205,894 |
|
|
|
211,751 |
|
|
|
|
|
|
|
|
|
|
Commitments and contingencies (Note 15) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ deficit: |
|
|
|
|
|
|
|
|
Common stock, |
|
|
7 |
|
|
|
7 |
|
Additional paid-in capital |
|
|
770,427 |
|
|
|
749,592 |
|
Accumulated deficit |
|
|
(851,233 |
) |
|
|
(765,851 |
) |
Total stockholders’ deficit |
|
|
(80,799 |
) |
|
|
(16,252 |
) |
Total liabilities and stockholders’ deficit |
|
$ |
125,095 |
|
|
$ |
195,499 |
|
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (in thousands, except for share data) |
||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
|
Twelve Months Ended
|
|
||||||||||
|
|
2022 |
|
|
2021 |
|
|
2022 |
|
|
2021 |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Revenues: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Products and software licenses |
|
$ |
34,934 |
|
|
$ |
44,685 |
|
|
$ |
148,922 |
|
|
$ |
151,172 |
|
Maintenance, warranty and services |
|
|
6,722 |
|
|
|
5,692 |
|
|
|
18,337 |
|
|
|
26,111 |
|
Total revenues |
|
|
41,656 |
|
|
|
50,377 |
|
|
|
167,259 |
|
|
|
177,283 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of revenues: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Products and software licenses |
|
|
20,588 |
|
|
|
28,837 |
|
|
|
95,335 |
|
|
|
95,442 |
|
Maintenance, warranty and services |
|
|
1,861 |
|
|
|
849 |
|
|
|
5,484 |
|
|
|
3,870 |
|
Total cost of revenues |
|
|
22,449 |
|
|
|
29,686 |
|
|
|
100,819 |
|
|
|
99,312 |
|
Gross profit |
|
|
19,207 |
|
|
|
20,691 |
|
|
|
66,440 |
|
|
|
77,971 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Research and development |
|
|
13,133 |
|
|
|
15,923 |
|
|
|
61,377 |
|
|
|
63,350 |
|
Sales and marketing |
|
|
5,028 |
|
|
|
8,682 |
|
|
|
30,587 |
|
|
|
33,839 |
|
General and administrative |
|
|
8,179 |
|
|
|
12,631 |
|
|
|
40,070 |
|
|
|
40,878 |
|
Amortization of intangibles |
|
|
284 |
|
|
|
294 |
|
|
|
1,136 |
|
|
|
1,191 |
|
Restructuring costs |
|
|
335 |
|
|
|
- |
|
|
|
1,279 |
|
|
|
- |
|
Total operating expenses |
|
|
26,959 |
|
|
|
37,530 |
|
|
|
134,449 |
|
|
|
139,258 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss from operations |
|
|
(7,752 |
) |
|
|
(16,839 |
) |
|
|
(68,009 |
) |
|
|
(61,287 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense, net |
|
|
(7,323 |
) |
|
|
(4,233 |
) |
|
|
(20,394 |
) |
|
|
(12,813 |
) |
Change in fair value of warrant liability and derivatives, net |
|
|
4,069 |
|
|
|
895 |
|
|
|
7,085 |
|
|
|
4,116 |
|
Gain on extinguishment of debt |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
2,096 |
|
Other (expense) income, net |
|
|
(452 |
) |
|
|
(743 |
) |
|
|
(4,261 |
) |
|
|
(3,328 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss before income taxes |
|
|
(11,458 |
) |
|
|
(20,920 |
) |
|
|
(85,579 |
) |
|
|
(71,216 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income tax (expense) benefit, net |
|
|
145 |
|
|
|
1,314 |
|
|
197 |
|
|
|
690 |
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss |
|
$ |
(11,313 |
) |
|
$ |
(19,606 |
) |
|
$ |
(85,382 |
) |
|
$ |
(70,526 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss per share - basic and diluted |
|
$ |
(0.15 |
) |
|
$ |
(0.27 |
) |
|
$ |
(1.17 |
) |
|
$ |
(1.09 |
) |
Weighted average shares outstanding - basic and diluted |
|
|
74,108,665 |
|
|
|
72,183,563 |
|
|
|
72,782,773 |
|
|
|
64,509,718 |
|
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (in thousands, except for share data) |
||||||||
|
|
|
|
|
|
|
|
|
|
|
Year Ended
|
|
|||||
|
|
2022 |
|
|
2021 |
|
||
Cash flows from operating activities: |
|
|
|
|
|
|
|
|
Net loss |
|
$ |
(85,382 |
) |
|
$ |
(70,526 |
) |
Adjustments to reconcile net loss to net cash used in operating activities: |
|
|
|
|
|
|
|
|
Depreciation and amortization |
|
|
4,622 |
|
|
|
4,294 |
|
Foreign exchange gain on long-term debt |
|
|
(16 |
) |
|
|
(14 |
) |
Gain on extinguishment of debt |
|
|
- |
|
|
|
(2,096 |
) |
Change in fair value of warrants and derivatives |
|
|
(7,085 |
) |
|
|
(7,940 |
) |
Non-cash debt waiver and amendment fees |
|
|
3,321 |
|
|
|
- |
|
Share-based compensation expense |
|
|
21,130 |
|
|
|
10,577 |
|
Loss on disposal of property, plant and equipment |
|
|
- |
|
|
|
22 |
|
Bad debt expense |
|
|
638 |
|
|
|
289 |
|
Total adjustments |
|
|
22,610 |
|
|
|
5,132 |
|
|
|
|
|
|
|
|
|
|
Changes in operating assets and liabilities: |
|
|
|
|
|
|
|
|
Decrease (increase) in accounts receivable |
|
|
10,777 |
|
|
|
12,352 |
|
(Increase) decrease in inventory |
|
|
(1,339 |
) |
|
|
(5,198 |
) |
Decrease in prepaid expenses and other current assets |
|
|
1,544 |
|
|
|
(6,547 |
) |
Increase in other operating assets |
|
|
535 |
|
|
|
(105 |
) |
(Decrease) increase in accounts payable |
|
|
(3,536 |
) |
|
|
(10,790 |
) |
Increase in deferred revenue |
|
|
(10 |
) |
|
|
(4,619 |
) |
Increase in accrued expenses and other current liabilities |
|
|
2,418 |
|
|
|
4,429 |
|
Increase in other long-term liabilities |
|
|
(5,728 |
) |
|
|
616 |
|
Increase in accrued interest on long-term debt |
|
|
10,947 |
|
|
|
8,571 |
|
Net cash used in operating activities |
|
|
(47,164 |
) |
|
|
(66,685 |
) |
|
|
|
|
|
|
|
|
|
Cash flows from investing activities: |
|
|
|
|
|
|
|
|
Purchase of property, plant and equipment |
|
|
(3,096 |
) |
|
|
(6,033 |
) |
Net cash used in investing activities |
|
|
(3,096 |
) |
|
|
(6,033 |
) |
|
|
|
|
|
|
|
|
|
Cash flows from financing activities: |
|
|
|
|
|
|
|
|
Repayments under senior term loan |
|
|
(5,280 |
) |
|
|
- |
|
Payment for taxes withheld on stock awards |
|
|
(295 |
) |
|
|
- |
|
Proceeds from the Business Combination, issuance of convertible debt and PIPE financing, net of issuance costs paid |
|
|
- |
|
|
|
115,501 |
|
Proceeds from the exercise of stock options |
|
|
- |
|
|
|
1,074 |
|
Proceeds from the sale of Series H stock, net |
|
|
- |
|
|
|
505 |
|
Proceeds from the issuance of Series H warrants |
|
|
- |
|
|
|
142 |
|
Net cash (used in) provided by financing activities |
|
|
(5,575 |
) |
|
|
117,222 |
|
|
|
|
|
|
|
|
|
|
Net (decrease) increase in cash, cash equivalents and restricted cash |
|
|
(55,835 |
) |
|
|
44,504 |
|
|
|
|
|
|
|
|
|
|
Cash, cash equivalents and restricted cash, beginning of year |
|
|
63,122 |
|
|
|
18,618 |
|
|
|
|
|
|
|
|
|
|
Cash, cash equivalents and restricted cash, end of year |
|
$ |
7,287 |
|
|
$ |
63,122 |
|
The following tables present the reconciliation of net loss, the most directly comparable GAAP measure, to Adjusted EBITDA:
|
|
Three Months Ended |
|
|||||
($ in thousands) |
|
|
|
|
|
|
||
Net loss |
|
$ |
(11,313 |
) |
|
$ |
(23,314 |
) |
|
|
|
|
|
|
|
|
|
Adjusted for: |
|
|
|
|
|
|
|
|
Interest expense, net |
|
|
7,323 |
|
|
|
4,296 |
|
Income tax (benefit) expense, net |
|
|
(145 |
) |
|
|
163 |
|
Depreciation and amortization |
|
|
1,174 |
|
|
|
1,173 |
|
EBITDA |
|
|
(2,961 |
) |
|
|
(17,682 |
) |
Share-based compensation expense |
|
|
1,731 |
|
|
|
5,863 |
|
Change in fair value of warrant liability and derivatives |
|
|
(4,069 |
) |
|
|
920 |
) |
Restructuring costs |
|
|
335 |
|
|
|
944 |
|
Adjusted EBITDA |
|
$ |
(4,964 |
) |
|
$ |
(9,955 |
) |
|
|
Three Months Ended
|
|
|||||
($ in thousands) |
|
2022 |
|
|
2021 |
|
||
Net loss |
|
$ |
(11,313 |
) |
|
$ |
(19,606 |
) |
|
|
|
|
|
|
|
|
|
Adjusted for: |
|
|
|
|
|
|
|
|
Interest expense, net |
|
|
7,323 |
|
|
|
4,233 |
|
Income tax (benefit) expense, net |
|
|
(145 |
|
|
(1,314 |
) |
|
Depreciation and amortization |
|
|
1,174 |
|
|
|
1,177 |
|
EBITDA |
|
|
(2,961 |
) |
|
|
(15,510 |
) |
Share-based compensation expense |
|
|
1,731 |
|
|
|
8,427 |
|
Change in fair value of warrant liability and derivatives |
|
|
(4,069 |
) |
|
|
(895 |
) |
Restructuring costs |
|
|
335 |
|
|
|
- |
|
Adjusted EBITDA |
|
$ |
(4,964 |
) |
|
$ |
(7,978 |
) |
|
|
Twelve Months Ended
|
|
|||||
($ in thousands) |
|
2022 |
|
|
2021 |
|
||
Net loss |
|
$ |
(85,382 |
) |
|
$ |
(70,526 |
) |
|
|
|
|
|
|
|
|
|
Adjusted for: |
|
|
|
|
|
|
|
|
Interest expense, net |
|
|
20,394 |
|
|
|
12,813 |
|
Income tax (benefit) expense, net |
|
|
(197 |
) |
|
|
(690 |
) |
Depreciation and amortization |
|
|
4,622 |
|
|
|
4,294 |
|
EBITDA |
|
|
(60,563 |
) |
|
|
(54,109 |
) |
Share-based compensation expense |
|
|
21,130 |
|
|
|
10,577 |
|
Change in fair value of warrant liability and derivatives |
|
|
(7,085 |
) |
|
|
(7,940 |
) |
Restructuring costs |
|
|
1,279 |
|
|
|
- |
|
Transaction costs allocated to the warrants |
|
|
- |
|
|
|
3,824 |
|
Management Incentive Plan expense related to Business Combination |
|
|
- |
|
|
|
18,513 |
|
Adjusted EBITDA |
|
$ |
(45,239 |
) |
|
$ |
(29,135 |
) |
View source version on businesswire.com: https://www.businesswire.com/news/home/20230316005718/en/
Media Contact:
mediarelations@airspan.com
Investor Relations Contact:
+1 561-893-8660
IR@airspan.com
Source:
FAQ
What were Airspan Networks' Q4 2022 revenue and gross margin figures?
How did Airspan Networks' full year 2022 revenue compare to 2021?
What was Airspan Networks' net loss for the full year 2022?
What improvements were noted in Airspan Networks' adjusted EBITDA for Q4 2022?